Dr. Gautum Agarwal, MD

Dr. Agarwal practices at Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD in Washington, Missouri.

Dr. Agarwal's NPI, 1780880633, was assigned on June 26, 2007. Dr. Agarwal graduated from Saint Louis University School Of Medicine in 2007. Dr. Agarwal holds Missouri license 2015018625.

Dr. Agarwal's primary practice is Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD, at 901 Patients First Dr, Washington, MO 63090.

Dr. Agarwal's primary practice is Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD in Washington, Missouri. Dr. Agarwal is also affiliated with Mercy Hospital Washington. The medical group on file is Mercy Hospital St. Louis. Dmand AI also links Dr. Agarwal to 4 more hospitals, 2 group practices and clinics, 1 home health agency, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Agarwal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 10 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Agarwal is board certified in urology by the American Board of Urology. Dmand AI has Dr. Agarwal's licenses on file in 3 states: Missouri, California and Florida.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Agarwal treats.

CMS data shows 762 Medicare services from Dr. Agarwal across 10 procedure codes in 2024, for 330 Medicare patients. Medicare paid $78,424 for them.

CMS counts 330 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 73, with 27% women.

In 2024, Dr. Agarwal wrote 936 Medicare Part D claims for 278 patients. 96% of them were for generic drugs. CMS names the drug for 789 of them, across 10 drugs with 11 or more claims each, at $6,104 in total drug cost. In 2023, CMS named 768 claims across 10 drugs.

Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agarwal as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Agarwal, published from 2011 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Kidney Neoplasms. Dr. Agarwal has published most often in Cancer Control. Dr. Agarwal's most frequent co-authors are Adam M. Luchey, MD, Michael A. Poch, MD and Julio M. Pow-Sang, MD.

CMS Open Payments shows 535 general payments to Dr. Agarwal from 71 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,185.

Dr. Agarwal graduated from Saint Louis University School Of Medicine in 2007.

Dr. Agarwal is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.